Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
1.
2.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
3.
How to secure philanthropic funding in a competitive climate
(feeds.nature.com)
5.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
6.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery
(feeds.content.dowjones.io)
9.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
10.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
11.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
12.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
13.
14.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
16.
Ozempic just released its own version of the iconic Mac vs. PC ad
(feeds.feedburner.com)
19.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)
20.
FDA Approves Pill Version of Wegovy
(wired.com)
21.
Today's top topics:
openai
nintendo
apple
sony
google
chatgpt
shinyhunters
apple watch
switch 2
android authority